WELCURE DRUG | A-1 ACID | WELCURE DRUG/ A-1 ACID |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 540.5 | 235.1 | 229.9% | View Chart |
P/BV | x | 3.9 | 8.5 | 46.0% | View Chart |
Dividend Yield | % | 0.0 | 0.4 | - |
WELCURE DRUG A-1 ACID |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WELCURE DRUG Mar-23 |
A-1 ACID Mar-23 |
WELCURE DRUG/ A-1 ACID |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | 390 | 3.0% | |
Low | Rs | 4 | 246 | 1.5% | |
Sales per share (Unadj.) | Rs | 0 | 287.5 | 0.0% | |
Earnings per share (Unadj.) | Rs | 0.1 | 3.2 | 2.4% | |
Cash flow per share (Unadj.) | Rs | 0.1 | 6.7 | 1.2% | |
Dividends per share (Unadj.) | Rs | 0 | 1.50 | 0.0% | |
Avg Dividend yield | % | 0 | 0.5 | 0.0% | |
Book value per share (Unadj.) | Rs | 1.1 | 42.1 | 2.7% | |
Shares outstanding (eoy) | m | 13.51 | 11.50 | 117.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 1.1 | - | |
Avg P/E ratio | x | 100.7 | 99.5 | 101.1% | |
P/CF ratio (eoy) | x | 97.5 | 47.6 | 204.7% | |
Price / Book Value ratio | x | 6.8 | 7.6 | 89.5% | |
Dividend payout | % | 0 | 47.0 | 0.0% | |
Avg Mkt Cap | Rs m | 102 | 3,656 | 2.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 13 | 2.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 3,306 | 0.0% | |
Other income | Rs m | 2 | 64 | 3.7% | |
Total revenues | Rs m | 2 | 3,369 | 0.1% | |
Gross profit | Rs m | -1 | 43 | -3.1% | |
Depreciation | Rs m | 0 | 40 | 0.1% | |
Interest | Rs m | 0 | 18 | 0.0% | |
Profit before tax | Rs m | 1 | 48 | 2.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 12 | 0.0% | |
Profit after tax | Rs m | 1 | 37 | 2.8% | |
Gross profit margin | % | 0 | 1.3 | - | |
Effective tax rate | % | 0 | 23.8 | 0.0% | |
Net profit margin | % | 0 | 1.1 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 458 | 0.0% | |
Current liabilities | Rs m | 0 | 143 | 0.1% | |
Net working cap to sales | % | 0 | 9.5 | - | |
Current ratio | x | 0.4 | 3.2 | 13.4% | |
Inventory Days | Days | 0 | 8 | - | |
Debtors Days | Days | 0 | 421 | - | |
Net fixed assets | Rs m | 15 | 236 | 6.5% | |
Share capital | Rs m | 134 | 115 | 116.9% | |
"Free" reserves | Rs m | -119 | 369 | -32.3% | |
Net worth | Rs m | 15 | 484 | 3.1% | |
Long term debt | Rs m | 0 | 47 | 0.0% | |
Total assets | Rs m | 15 | 694 | 2.2% | |
Interest coverage | x | 0 | 3.6 | - | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0 | 4.8 | 0.0% | |
Return on assets | % | 6.7 | 7.9 | 83.9% | |
Return on equity | % | 6.7 | 7.6 | 88.5% | |
Return on capital | % | 6.7 | 12.5 | 53.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1 | 187 | 0.6% | |
From Investments | Rs m | 13 | -35 | -37.5% | |
From Financial Activity | Rs m | -15 | -153 | 9.8% | |
Net Cashflow | Rs m | -1 | 0 | 180.6% |
Indian Promoters | % | 0.0 | 70.0 | - | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 2.9 | - | |
FIIs | % | 0.0 | 2.9 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 100.0 | 30.0 | 333.7% | |
Shareholders | 31,530 | 2,028 | 1,554.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare WELCURE DRUG With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | WELCURE DRUG | A-1 ACID | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -4.97% | 0.07% | -0.44% |
1-Month | 11.68% | 3.31% | -0.19% |
1-Year | 8.91% | 0.83% | 53.63% |
3-Year CAGR | 27.96% | 56.59% | 14.59% |
5-Year CAGR | 57.09% | 47.07% | 19.77% |
* Compound Annual Growth Rate
Here are more details on the WELCURE DRUG share price and the A-1 ACID share price.
Moving on to shareholding structures...
The promoters of WELCURE DRUG hold a 0.0% stake in the company. In case of A-1 ACID the stake stands at 70.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WELCURE DRUG and the shareholding pattern of A-1 ACID.
Finally, a word on dividends...
In the most recent financial year, WELCURE DRUG paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
A-1 ACID paid Rs 1.5, and its dividend payout ratio stood at 47.0%.
You may visit here to review the dividend history of WELCURE DRUG, and the dividend history of A-1 ACID.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.